reprai, founded in 2024, is a pioneering company headquartered in the United States and operates at the intersection of AI, IT, Pharmaceutical, and CRM sectors. The company's mission is succinctly captured in its slogan: "Redefining Pharma Engagement with AI Precision".
Dedicated to transforming how pharmaceutical companies engage with healthcare professionals, reprai employs AI-powered technology to enhance and streamline interactions. By deploying advanced segmentation and personalization strategies, the platform ensures that each communication is highly tailored, leveraging diverse digital channels. Continuous learning and improvement are embedded into its processes, while prioritizing data security.
The company recently secured a $1.00M early VC investment on 01 January 2026, with backing from Arya Women's Investment Platform and Simya VC. This investment underscores confidence in reprai's innovative approach and growth potential in the pharmaceutical engagement space.